MICHAEL KOBERNICK
- Type
- Physician · Allopathic & Osteopathic Physicians / Emergency Medicine
- Where
- WARREN, MI
- NPI
- 1659305076
- Received
- $137,173 in 112 records, 2020 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 47 | $45,259 |
| 2024 | General payment | 9 | $22,281 |
| 2023 | General payment | 21 | $26,401 |
| 2022 | General payment | 18 | $20,308 |
| 2021 | General payment | 13 | $15,372 |
| 2020 | General payment | 4 | $7,550 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $19,402 | 2021–2025 |
| Johnson & Johnson Health Care Systems Inc. | 8 | $16,204 | 2023–2025 |
| Incyte Corporation | 13 | $15,358 | 2020–2024 |
| Novo Nordisk Inc | 9 | $14,085 | 2021–2025 |
| bioMerieux Inc | 4 | $11,446 | 2024 |
| Abbott Laboratories | 11 | $7,159 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $5,462 | 2023 |
| Novartis Pharmaceuticals Corporation | 6 | $5,459 | 2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | 7 | $5,347 | 2021–2022 |
| E.R. Squibb & Sons, L.L.C. | 3 | $5,170 | 2023 |
| Biogen, Inc. | 2 | $4,550 | 2020–2021 |
| ViiV Healthcare Company | 3 | $3,612 | 2023 |
| Horizon Therapeutics plc | 4 | $3,430 | 2020–2023 |
| GlaxoSmithKline, LLC. | 1 | $2,600 | 2022 |
| SOBI, INC | 1 | $2,212 | 2025 |
| PFIZER INC. | 5 | $2,145 | 2025 |
| AstraZeneca UK Limited | 1 | $2,000 | 2024 |
| EMD Serono, Inc. | 1 | $1,890 | 2025 |
| Apellis Pharmaceuticals, Inc. | 1 | $1,800 | 2022 |
| Genentech USA, Inc. | 1 | $1,760 | 2021 |
| Invivyd Inc | 1 | $1,700 | 2025 |
| Eisai Inc. | 1 | $1,290 | 2021 |
| Amgen Inc. | 1 | $1,277 | 2024 |
| EVOKE PHARMA, INC. | 1 | $1,200 | 2025 |
| Ionis Pharmaceuticals, Inc. | 1 | $425 | 2025 |
| Boehringer Ingelheim International GmbH | 1 | $183 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 48 | $117,074 |
| Travel and Lodging | 36 | $12,780 |
| Honoraria | 5 | $4,630 |
| Food and Beverage | 22 | $2,101 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $586 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | Boehringer Ingelheim International GmbH | $183 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-12-10 | Johnson & Johnson Health Care Systems Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-12-08 | EMD Serono, Inc. | $1,890 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-30 | SOBI, INC | $2,212 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-24 | Abbott Laboratories | $6,162 | Consulting Fee | Cash or cash equivalent | AFINION 2 Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $237 | Travel and Lodging | In-kind items and services | AFINION 2 Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $236 | Travel and Lodging | In-kind items and services | AFINION 2 Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $175 | Travel and Lodging | In-kind items and services | AFINION 2 Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $157 | Food and Beverage | In-kind items and services | AFINION HBA1C DX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $65 | Food and Beverage | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $38 | Travel and Lodging | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $35 | Travel and Lodging | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $26 | Food and Beverage | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $9 | Travel and Lodging | In-kind items and services | AFINION 2 Device, Rapid Diagnostics | 2025 | |
| 2025-07-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $645 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7,740 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-07-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-29 | PFIZER INC. | $586 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LITFULO Drug, IMMUNOLOGY | 2025 | |
| 2025-07-17 | Ionis Pharmaceuticals, Inc. | $425 | Consulting Fee | Cash or cash equivalent | TRYNGOLZA Drug, CARDIOLOGY | 2025 | |
| 2025-07-16 | EVOKE PHARMA, INC. | $1,200 | Honoraria | Cash or cash equivalent | GIMOTI Drug, Gastroenterology | 2025 | |
| 2025-07-10 | PFIZER INC. | $509 | Travel and Lodging | In-kind items and services | LITFULO Drug, IMMUNOLOGY | 2025 | |
| 2025-07-10 | PFIZER INC. | $436 | Food and Beverage | In-kind items and services | LITFULO Drug, IMMUNOLOGY | 2025 | |
| 2025-07-10 | PFIZER INC. | $355 | Travel and Lodging | In-kind items and services | LITFULO Drug, IMMUNOLOGY | 2025 | |
| 2025-07-10 | PFIZER INC. | $257 | Travel and Lodging | In-kind items and services | LITFULO Drug, IMMUNOLOGY | 2025 | |
| 2025-06-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $64 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-05-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $47 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $46 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $37 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $37 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | $633 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-05-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | $751 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-24 | Invivyd Inc | $1,700 | Consulting Fee | Cash or cash equivalent | PEMGARDA Biological, INFECTIOUS DISEASE | 2025 | |
| 2025-04-17 | Johnson & Johnson Health Care Systems Inc. | $3,950 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-17 | Johnson & Johnson Health Care Systems Inc. | $406 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-04-17 | Johnson & Johnson Health Care Systems Inc. | $75 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-17 | Johnson & Johnson Health Care Systems Inc. | $48 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-04-10 | Novo Nordisk Inc | $272 | Consulting Fee | Cash or cash equivalent | Saxenda Drug, Obesity | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $6,131 | Consulting Fee | Cash or cash equivalent | Saxenda Drug, Obesity | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $511 | Travel and Lodging | In-kind items and services | Saxenda Drug, Obesity | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $497 | Travel and Lodging | In-kind items and services | Saxenda Drug, Obesity | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $270 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $215 | Travel and Lodging | In-kind items and services | Saxenda Drug, Obesity | 2025 | |
| 2025-04-01 | Novo Nordisk Inc | $1,090 | Consulting Fee | Cash or cash equivalent | Saxenda Drug, Obesity | 2025 | |
| 2025-02-13 | Novo Nordisk Inc | $1,907 | Consulting Fee | Cash or cash equivalent | Drug | 2025 | |
| 2025-01-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,290 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2024-12-04 | Johnson & Johnson Health Care Systems Inc. | $1,125 | Consulting Fee | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-12-02 | Johnson & Johnson Health Care Systems Inc. | $4,700 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-05-09 | Amgen Inc. | $1,277 | Consulting Fee | Cash or cash equivalent | TEPEZZA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-03-12 | AstraZeneca UK Limited | $2,000 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-01-10 | bioMerieux Inc | $7,700 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-01-10 | bioMerieux Inc | $3,023 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-01-10 | bioMerieux Inc | $597 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-01-10 | bioMerieux Inc | $125 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-01-04 | Incyte Corporation | $1,732 | Consulting Fee | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2024 | |
| 2023-12-08 | ViiV Healthcare Company | $3,375 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-11-17 | ViiV Healthcare Company | $125 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-11-17 | ViiV Healthcare Company | $112 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-11-16 | Johnson & Johnson Health Care Systems Inc. | $4,400 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-06-16 | Horizon Therapeutics plc | $400 | Honoraria | Cash or cash equivalent | TEPEZZA Drug, TEPEZZA | 2023 | |
| 2023-06-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,500 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $449 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $231 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $190 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $90 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-03-31 | Incyte Corporation | $94 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-03-30 | Incyte Corporation | $5,445 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-03-30 | Incyte Corporation | $107 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-03-30 | Incyte Corporation | $79 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-03-30 | Incyte Corporation | $70 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-03-30 | Incyte Corporation | $32 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-03-29 | Incyte Corporation | $236 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-03-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,290 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-02-10 | E.R. Squibb & Sons, L.L.C. | $4,314 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-01-27 | E.R. Squibb & Sons, L.L.C. | $552 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2023-01-27 | E.R. Squibb & Sons, L.L.C. | $303 | Travel and Lodging | Cash or cash equivalent | 2023 | ||
| 2022-12-20 | GlaxoSmithKline, LLC. | $2,600 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-12-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,020 | Consulting Fee | Cash or cash equivalent | SPEVIGO Drug, IMMUNOLOGY | 2022 | |
| 2022-12-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | SPEVIGO Drug, IMMUNOLOGY | 2022 | |
| 2022-12-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | SPEVIGO Drug, IMMUNOLOGY | 2022 | |
| 2022-12-08 | Novartis Pharmaceuticals Corporation | $4,762 | Consulting Fee | Cash or cash equivalent | COSENTYX Biological, IMMUNOLOGY | 2022 | |
| 2022-11-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $851 | Travel and Lodging | In-kind items and services | SPEVIGO Drug, IMMUNOLOGY | 2022 | |
| 2022-11-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $133 | Travel and Lodging | In-kind items and services | SPEVIGO Drug, IMMUNOLOGY | 2022 | |
| 2022-11-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $43 | Food and Beverage | In-kind items and services | SPEVIGO Drug, IMMUNOLOGY | 2022 | |
| 2022-11-12 | Novartis Pharmaceuticals Corporation | $229 | Travel and Lodging | Cash or cash equivalent | COSENTYX Biological, IMMUNOLOGY | 2022 | |
| 2022-11-12 | Novartis Pharmaceuticals Corporation | $178 | Travel and Lodging | In-kind items and services | COSENTYX Biological, IMMUNOLOGY | 2022 | |
| 2022-11-12 | Novartis Pharmaceuticals Corporation | $113 | Food and Beverage | In-kind items and services | COSENTYX Biological, IMMUNOLOGY | 2022 | |
| 2022-11-12 | Novartis Pharmaceuticals Corporation | $90 | Travel and Lodging | In-kind items and services | COSENTYX Biological, IMMUNOLOGY | 2022 | |
| 2022-11-11 | Incyte Corporation | $1,200 | Consulting Fee | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2022 | |
| 2022-11-11 | Novartis Pharmaceuticals Corporation | $85 | Food and Beverage | In-kind items and services | COSENTYX Biological, IMMUNOLOGY | 2022 | |
| 2022-10-25 | Apellis Pharmaceuticals, Inc. | $1,800 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-07-20 | VERTEX PHARMACEUTICALS INCORPORATED | $1,162 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-02-18 | Incyte Corporation | $1,700 | Consulting Fee | Cash or cash equivalent | OPZELURA Drug, Dermatology | 2022 | |
| 2022-01-26 | VERTEX PHARMACEUTICALS INCORPORATED | $1,162 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2021-11-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,420 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-11-10 | VERTEX PHARMACEUTICALS INCORPORATED | $581 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-10-20 | VERTEX PHARMACEUTICALS INCORPORATED | $232 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-09-28 | Genentech USA, Inc. | $1,760 | Consulting Fee | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | 2021 | |
| 2021-09-15 | VERTEX PHARMACEUTICALS INCORPORATED | $465 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-09-11 | Eisai Inc. | $1,290 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-08-27 | Biogen, Inc. | $1,750 | Consulting Fee | Cash or cash equivalent | SPINRAZA Biological, NEUROLOGY | 2021 | |
| 2021-08-18 | VERTEX PHARMACEUTICALS INCORPORATED | $1,162 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-07-26 | Novo Nordisk Inc | $3,190 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-06-09 | VERTEX PHARMACEUTICALS INCORPORATED | $581 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-05-04 | Incyte Corporation | $1,190 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-04-12 | Horizon Therapeutics plc | $700 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2021 | |
| 2021-03-12 | Horizon Therapeutics plc | $1,050 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2021 | |
| 2020-11-13 | Incyte Corporation | $2,210 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-09-22 | Horizon Therapeutics plc | $1,280 | Honoraria | Cash or cash equivalent | DUEXIS Drug, DUEXIS | 2020 | |
| 2020-08-21 | Biogen, Inc. | $2,800 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-03-19 | Incyte Corporation | $1,260 | Consulting Fee | Cash or cash equivalent | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Warren, MI, county Macomb County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Warren, MI | County Macomb County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 137,928 | 879,853 | 10,077,761 |
| Population, 2020 census P1 | 139,387 | 881,217 | 10,077,331 |
| Median age B01002 | 38.3 | 41.3 | 40.2 |
| Under 18 B01001 | 21.9% | 20.6% | 21.2% |
| 65 and over B01001 | 16.5% | 18.3% | 18.6% |
| Households B11001 | 54,744 | 358,668 | 4,076,369 |
| Foreign born B05002 | 14.3% | 11.7% | 7.2% |
| Median household income B19013 | $64,016 | $77,837 | $72,875 |
| Median family income B19113 | $76,136 | $98,113 | $93,357 |
| Per capita income B19301 | $33,015 | $40,619 | $40,735 |
| Poverty rate B17001 | 14.8% | 10.4% | 13.2% |
| Unemployment rate B23025 | 8.0% | 5.7% | 5.7% |
| Civilian labor force B23025 | 71,048 | 459,271 | 5,018,449 |
| Mean commute (minutes) B08013 | 24.9 | 26.3 | 24.2 |
| Bachelor's degree or higher B15003 | 21.0% | 27.7% | 32.4% |
| Housing units B25001 | 57,958 | 373,413 | 4,622,236 |
| Owner-occupied B25003 | 71.1% | 75.0% | 73.2% |
| Renters B25003 | 28.9% | 25.0% | 26.8% |
| Median home value B25077 | $193,400 | $243,900 | $231,600 |
| Median gross rent B25064 | $1,225 | $1,211 | $1,129 |
| White, not Hispanic B03002 | 58.0% | 74.1% | 72.4% |
| Black B03002 | 21.8% | 12.7% | 13.1% |
| Hispanic or Latino B03002 | 2.4% | 3.2% | 5.9% |
| Asian B03002 | 12.7% | 5.1% | 3.4% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Warren, MI.
Comments